Ocaliva FDA Approval History
FDA Approved: Yes (First approved May 27, 2016)
Brand name: Ocaliva
Generic name: obeticholic acid
Dosage form: Tablets
Company: Intercept Pharmaceuticals, Inc.
Treatment for: Primary Biliary Cholangitis
Ocaliva (obeticholic acid) is a first-in-class farnesoid X receptor (FXR) agonist for the treatment of primary biliary cholangitis.
Development timeline for Ocaliva
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.